Johnson & Johnson’s seltorexant is one of two new therapies that the company reckons could become blockbuster treatments for depression, and data from a phase 3 trial keeps that hope alive. Topline ...

Major depressive disorder (MDD) is a severe form of depression characterized by a persistent low mood, hopelessness, disruptions in sleep and/or eating habits, as well as a loss of motivation and ...

Struggling with depression or anxiety can feel overwhelming-and deciding whether to start a medication like Effexor adds ...

Fibromyalgia is a condition causing body pain, fatigue, and trouble sleeping. Scientists don't really know what causes it, but it's known that if you have a heightened sensitivity to pain, you're more ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Effexor® SR 37.5 mg / 75 mg capsules (venlafaxine ...

Overdosing on antidepressants is possible with any type, though tricyclic antidepressants carry the highest risk of fatal outcomes compared to SSRIs, SNRIs, or MAOIs. Symptoms of antidepressant ...

The concurrent use of serotonergic antidepressants (SSRIs, SNRIs) and opioid analgesics is frequent in the perioperative setting. While this combination carries a known risk of serotonin syndrome, ...

Objective Examine the association between the co-prescribing of opioids, benzodiazepines, gabapentinoids (pregabalin and gabapentin) and selective serotonin reuptake inhibitors/serotonin and ...

Pristiq and Effexor are both SNRIs prescribed to treat depression in adults. Pristiq is only approved to treat depression, while Effexor is approved for depression and anxiety disorders. Pristiq may ...

Cymbalta and Lexapro are both used to treat depression and anxiety disorders, but they are different drug classes. Cymbalta is also approved to treat nerve pain and fibromyalgia in adults. Lexapro ...